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ABSTRACT  
 
The transmission of disease or infection from the donor to the recipient is always a risk 
with the use of allografts. We carried out a research study on the behavioural pattern of 
implanted allografts, which were initially stored in perfect conditions (all cultures being 
negative) but later presented positive cultures at the implantation stage. Because there is 
no information available on how to deal with this type of situation, our aim was to set 
guidelines on the course of action which would be required in such a case. We 
conducted a retrospective study of 181 patients who underwent an ACL reconstruction 
using BPTB allografts. All previous bone and blood cultures and tests for hepatitis B 
and C, syphilis and HIV were negative. An allograft sample was taken for culture in the 
operating theatre just before its implantation. The results of the cultures were obtained 
3–5 days after the operation. We had 24 allografts with positive culture (13.25%) after 
the implantation with no clinical infection in any of these patients. Positive cultures 
could be caused by undetected contamination while harvesting, storing or during 
manipulation before implantation. The lack of clinical signs of infection during the 
follow-up of our patients may indicate that no specific treatment – other than an 
antibiotic protocol – would be required when facing a case of positive culture of a graft 
piece after its implantation. 
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INTRODUCTION 
 
Although the performance of bone–patellar tendon-bone (BPTB) autografts sets the 
gold standard in the reconstruction of the anterior cruciate ligament (ACL), more 
allografts are being used since the paper by Shino and colleagues [24]. Most published 
articles show that similar results can be achieved with BPTB allografts [8, 13, 15, 18, 
20, 23]. There is always a potential risk of transmitting disease or infection from the 
donor to the recipient when using allografts [27, 28]. Since 1988, only eight cases of 
bone transplantation-associated HIV infection have been reported, although bacterial 
allograft infection is more common [14]. However, to the best of the author’s 
knowledge there are no papers published on what to do with a contaminated implanted 
allograft. Although we suppose that septic arthritis after ACL reconstruction is caused 
by allograft contamination, there are no clinical studies which prove this [3]. This lack 
of information does not provide us with any tools whatsoever as to the course of action 
that should be taken. This paper focuses on the actual incidence of implanted BPTB 
allografts which are initially non-contaminated, and on their possible clinical 
repercussion. 
  
  
MATERIALS AND METHODS 
 
A retrospective review was conducted of the medical records of all 181 patients with 
anterior cruciate ligament reconstruction using BPTB allograft between December 1987 
and December 2001. Part of this series was previously published showing our clinical 
results with BPTB allografts [29, 30, 31]. All patients were operated on at our knee 
surgery division. 
 
International bone bank screening procedures were followed for all donors. All of our 
tissue bank allografts were extracted in an operating room from donors of cadavers by 
means of sterile routine techniques (many of them were also organ donors), and 
immediately put in a sterile plastic recipient that was enclosed in two closed sterile 
plastic bags and frozen at –80°. Prior to storage a sample for culture was taken from all 
tissues, [1, 17, 22]. Blood cultures and tests for hepatitis B and C, syphilis and HIV (via 
PCR techniques) were also carried out. All allografts whose culture resulted positive, or 
whose donor was affected with any of the mentioned infections, were discharged. Grafts 
free of bacterial contamination or donor infections were kept and stored frozen at –80°C 
in another electric freezer equipped with an alarm to ensure that tissues were stored in 
perfect conditions until they were to be used. Allografts were stored for a maximum of 
2 years. No secondary sterilization methods were used, because none of them ensures 
the complete sterilization of the graft without damaging the structure of the graft [11, 
25]. 
 
A graft sample was taken in each case for culture in the operating theatre just before its 
implantation in the patient. In a previous study we found that this is the most reliable 
method for cultures [17]. The graft had previously been washed in three litres of sterile 
physiologic fluid. The same culture methods were used for all samples. The sample was 
collected in a sterile container. In total, 4ml of trypticase soy broth (TSB) was added 
and was shacked with a vortex. This was inoculated in blood agar, chocolate blood agar 
and thioglycollate broth. The blood agar and chocolate blood agar were incubated at 
35°C in the presence of 10% CO2. The thioglycollate broth and the TSB with specimen 
were incubated at 35°C. The cultures underwent observation for 5 days. The same 
method of culturing allografts was used during the recovery and processing phases and 
when opened in the operating room for clinical implantation. 
 
If after the 5-day period no growth whatsoever was found on the plates, in the 
thioglycollate broth, or in TSB the sample was considered negative. If there was growth 
on the plates, it was considered important, whereas if growth was detected in the 
thioglycollate broth or in TSB, but not on the plate it was considered to be poor. 
We reviewed 181 patients who underwent an anterior cruciate ligament reconstruction. 
The average age was 25 years (16–48). BPTB allograft from our bone bank was used in 
all cases. Oncologic patients or those with immunodeficiency were excluded from this 
revision. 
 
We indicated in all patients the prophylactic antibiotic protocol recommended by the 
Clinical Infections Committee of our hospital. This protocol consisted of administering 
endovenous Cefazolin 1 g/day 30 min before surgery and another gram every 8 h for 2 
days. Clindamicine 600 mg/8h and Gentamicine 1.7 mg/kg per day were used if 
Cefazolin was contraindicated. In the case of positive culture, oral antibiotic treatment 
was prescribed for 2 weeks following the antibiogram. 
 
Routine wound and temperature controls were performed until the patient was 
discharged from the hospital, as well as in posterior clinical examinations. We 
considered laboratory tests to be unnecessary because of the lack of clinical signs. 
 
 
RESULTS 
 
Positive cultures appeared in 24 allografts after their implantation (13.25%). Cultures 
tests proved positive for Staphylococci coagulase negative (ECN) in ten grafts (41.6%), 
Corynebacterium jeikeium in six grafts (25%), Micrococcus and Propionibacterium 
granulosus in two grafts each (8.3%), and each of the following appeared once (4.1%): 
E. Colli, Bacillus brevis, Agribacterium radiobacter/SCN, Propionibacterium acnes. We 
found abundant bacterial growth in 3 cases (12.5%; ECN, Corynebacterium jeikeium, 
Agribacterium radiobacter/ and SCN), and in 21 cases (87.5%) growth was classified as 
poor (Table 1). Using our prophylactic antibiotic protocol, and with an average follow-
up of 49.5 months (range 12–150), no clinical infection was detected in any of these 
patients. 
 
 
DISCUSSION 
 
The first bone banks appeared in the 1940s but thanks to a long series published by 
Malinin (1976) and Mankin (1983) the use of human allografts became universal 
practice [26]. Today this practice in Spain is controlled by the National Transplantation 
Organization (NTO), who sets the guidelines for proper donor selection, graft extraction 
storage distribution and implantation. In the year 2000 a total of 60 bone banks were 
registered at the NTO. 
 
Although autografts are the gold standard in ACL reconstruction, the use of BPTB 
allografts has been shown to be increasing progressively [15, 23]. The use of autografts 
does have its drawbacks due to harvesting and donor site morbidity. Furthermore, 
autograft harvesting increases operating time, and gives rise to the risk of patella 
fracture, patella tendonitis and residual tender scars [12]. On the other hand, advantages 
such as the unlimited supply of grafts, diminished surgical time and the absence of 
donor site morbidity [23] make allografts a very interesting option. Moreover, several 
studies have shown that the risk of transmitting diseases is acceptable and results are 
almost similar to the ones obtained with autografts [2, 17, 19, 27]. 
 
The transmission of disease or infection by the donor to the recipient is always a risk 
when resorting to the use of allografts, but the prevalence is low [16, 28], being lower 
than the risk of transmission by the transplantation of organs. Since 1988, only eight 
cases of bone transplantation-associated HIV infection have been reported [14]. Gamma 
irradiation of allografts is not effective in HIV inactivation at the levels currently used. 
Therefore, good screening procedures are the most effective means for providing the 
safest possible allografts [9, 10, 21, 25]. No viral transmission has been registered in our 
bone bank since it was set up in 1986. Tomford et al. found an incidence of infection 
related to the use of allografts of 5% in patients who had treatment for bone tumours, 
and of 4% in those who had revision of a hip arthroplasty [27] These rates of infection 
were not substantially different from those that have been reported in similar series in 
which large allografts or sterilized prosthetic devices were used. The causes of infection 
were difficult to determine, but contamination of the allograft was probably not a factor 
in most patients. By March 2002, the CDC had received 26 reports of bacterial 
infections associated with musculoskeletal tissue allografts, 13 infected with 
Clostridium spp., including one death [3]. 
 
The best way to avoid infection or diminish its incidence is careful donor selection and 
the application of routine sterile techniques when dealing with bacterial cultures at the 
extraction, storage and implantation stages of the allografts. 
 
Nevertheless, what course of action can be taken when a culture from an implanted 
BPTB allograft (with all extraction and storage cultures proving negative) turns out to 
be positive? Although we always perform routine cultures just before implantation, the 
results are not available until 5 days later. Consequently, we are faced with the task of 
determining what to do when any of those cultures prove to be positive. Should the 
implanted graft be removed? 
 
We have reviewed more than 50 papers on general bone banking, and to the best of the 
author’s knowledge there is no information concerning the issue covered in our research 
study in any of these papers or in the greatly recommended books by Friedlander et al. 
[7], the EAMST (European Association of Musculo-Skeletal Transplantation) [6] and 
Czitrom [4]. Therefore, the experience that we are reporting now could prove to be 
useful in broadening our knowledge of potential problems that occur during bone and 
soft tissue transplantation and their treatment. 
 
The satisfactory behaviour of our contaminated grafts, the poor growth and the type of 
bacteria found in most of our positive cultures all indicates the possibility of a 
laboratory contaminant. However the positive culture rate of our grafts was higher than 
our laboratory contamination rate, which is under 5%. We also found extensive growth 
in three of the implanted grafts. In short, there is substantial evidence to state that 
positive cultures could be caused by non-detected contamination during the stages of 
harvesting, storage or their manipulation before implantation. Davis and colleagues [5] 
studied the contamination rates in samples from the surgical suckers, bladders and 
needles; the organisms and contamination rates found were similar to those in our study 
(skin commensals) and the rate of infection was 1% (with the infecting organism 
different from that found in the surgical instruments). Our results show that 
contamination of the allografts in the operating theatre is as frequent as the 
contamination of the surgical equipment. 
 
The lack of clinical signs of infection during the follow-up of our patients may indicate 
that no specific treatment – other than our antibiotic protocol – is needed when facing 
the case of a positive culture of a graft piece after implantation. Therefore, in our 
opinion no other special antibiotic preventive therapy or surgical treatment is required. 
At any rate, we must take great care as to the micro-organism and the antibiogram in 
order to remove the allograft and use specific antibiotics in cases where very 
pathogenous bacteria, such as Clostridium, are found. Therefore it is important to obtain 
cultures before and after processing the allograft in order to identify any contaminant. 
In cases in which skin commensals are the contaminant, the possibility of obtaining the 
same results with a simpler preventive antibiotic therapy – such as the one we currently 
use when not implanting allografts, or when no positive cultures are negative after 
implantation – is now under consideration by the Clinical Infections Committee of our 
Hospital. A prospective study will follow. 
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Table 1. Patients and results 
Patient Age Gender Bacteria Growth Follow-up 
1 17 Male Staphylococci coagulase negative Poor 150 
2 22 Female Staphylococci coagulase negative Poor 138 
3 27 Male Staphylococci coagulase negative Important 90 
4 20 Male Propinebacterium granulosus Poor 90 
5 34 Male Propinebacterium acnes Poor 90 
6 35 Male Corynebacterium jeikeium Important 78 
7 29 Female Staphylococci coagulase negative Poor 66 
8 23 Male Corynebacterium jeikeium Poor 66 
9 21 Female Corynebacterium jeikeium Poor 66 
10 33 Male Agribacterium radiobacter/SCN Important 54 
11 33 Male Staphylococci coagulase negative Poor 54 
12 29 Male Corynebacterium jeikeium Poor 54 
13 25 Male Bacillus brevis Poor 54 
14 32 Male Micrococcus Poor 30 
15 23 Male E. colli Poor 30 
16 30 Male Staphylococci coagulase negative Poor 30 
17 46 Female Staphylococci coagulase negative Poor 30 
18 27 Male Micrococcus Poor 18 
19 35 Male Corynebacterium jeikeium Poor 18 
20 41 Male Propionibacterium granulosus Poor 18 
21 17 Male Staphylococci coagulase negative Poor 12 
22 16 Female Corynebacterium jeikeium Poor 12 
23 32 Male Staphylococci coagulase negative Poor 12 
24 23 Male Staphylococci coagulase negative Poor 12 
 
